Clinical Nutrition For Cancer Care Market Forecast: How Big Will It Be by 2030?
Uncover key drivers, emerging technologies, and competitive movements shaping the clinical nutrition for cancer care market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Clinical Nutrition For Cancer Care Market?
The clinical nutrition for cancer care market has experienced robust expansion in recent years. It is projected to climb from $5.16 billion in 2025 to $5.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical growth in this market can be ascribed to several factors, including the increasing incidence of cancer cases, the expansion of oncology treatment centers, rising awareness of nutrition in cancer outcomes, the growth in clinical nutrition programs, and the availability of specialized oncology nutrition products.
The market for clinical nutrition in cancer care is anticipated to experience consistent expansion in the coming years. By 2030, this market is projected to reach $6.5 billion, achieving a compound annual growth rate (CAGR) of 4.6%. This projected growth is driven by several factors, including an increased emphasis on tailored oncology care, a heightened need for high-protein and immune-boosting nutritional products, the spread of outpatient cancer treatment approaches, wider use of digital tools for nutrition monitoring, and a greater focus on enhancing the quality of life for patients undergoing cancer therapy. Key trends expected during this period involve the rising implementation of customized nutrition strategies for cancer patients, a growing application of specialized enteral and parenteral formulations, the increasing incorporation of nutritional monitoring technologies, the expansion of clinical nutrition support delivered in home settings, and a sharper focus on dietary interventions specific to symptoms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16017&type=smp
Which Drivers Are Supporting The Rise Of The Clinical Nutrition For Cancer Care Market?
The escalating incidence of cancer is anticipated to fuel the expansion of the clinical nutrition for cancer care market in the coming years. Cancer defines a collection of illnesses marked by unchecked cellular proliferation and the capacity to metastasize to various body regions. The increase in cancer occurrences is linked to longer lifespans, rendering a greater proportion of the elderly population more vulnerable to the disease. Clinical nutrition for cancer care involves offering specialized dietary administration and nutritional aid specifically designed for the distinct requirements of cancer patients, with the goal of enhancing treatment results. For example, in February 2024, the World Health Organization, a US-based intergovernmental organization, projected approximately 35 million new cancer cases by 2050, representing a 77% surge from the estimated 20 million cases in 2022. Consequently, the increasing prevalence of cancer is a key factor propelling the growth of the clinical nutrition for cancer care market.
What Leading Segments Are Studied In The Clinical Nutrition For Cancer Care Market?
The clinical nutrition for cancer care market covered in this report is segmented –
1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
3) By Age Group: Adult, Pediatric
4) By Sales Channel: Online, Retail, Institutional Sales
Subsegments:
1) By Oral Nutrition: Protein-Rich Supplements, Carbohydrate-Rich Supplements, Fat-Rich Supplements, Vitamins And Mineral Supplements, Caloric Supplements, Fiber-Enriched Supplements
2) By Parenteral Nutrition: Amino Acids, Carbohydrates, Lipids, Electrolytes And Micronutrients, Intravenous Fat Emulsions, Trace Elements And Vitamins
3) By Enteral Feeding Formulas: Standard Enteral Feeding Formulas, High-Protein Enteral Formulas, High-Calorie Enteral Formulas, Diabetic Enteral Formulas, Elemental Enteral Formulas, Specialized Enteral Formulas
Which Market Trends Are Opening Growth Opportunities In The Clinical Nutrition For Cancer Care Market?
Major companies engaged in the clinical nutrition for cancer care market are prioritizing the adoption of data-driven methods and advanced genomic profiling. Their objective is to provide personalized cancer care, enhance treatment results, and refine therapy selection for individual patients. Advanced genomic profiling involves a comprehensive examination of a patient’s genetic material to pinpoint mutations and biomarkers that guide personalized cancer diagnosis, treatment, and prognosis. For instance, in December 2024, Aster DM Healthcare, an UAE-based healthcare provider, launched Precision Oncology, a platform that delivers personalized cancer care through extensive genomic analysis, biomarker identification, and data-informed treatment recommendations. This initiative aims to enable the development of tailored therapy plans, optimize clinical decision-making, and improve overall patient outcomes by integrating advanced diagnostics with precision medicine strategies.
Which Major Firms Are Strengthening Their Position In The Clinical Nutrition For Cancer Care Market?
Major companies operating in the clinical nutrition for cancer care market are Abbott Nutrition, Baxter International Inc., B Braun Melsungen AG, Nestle Health Science S A, Danone Nutricia, Hormel Health Labs, Evonik Industries AG, Otsuka Holdings Co Ltd, Koninklijke DSM N V, Glanbia plc, Meiji Holdings Company Ltd, Victus Inc., Global Health Products Inc., Fresenius Kabi AG, Perrigo Company plc, Arla Foods Ingredients Group P S, Kerry Group plc, Lonza Group AG, Ajinomoto Co Inc., Yakult Honsha Co Ltd, Rousselot BV, Tate Lyle plc, ADM Human Nutrition, Vitaflo International Ltd, Smartfish AS, Medtrition Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Clinical Nutrition For Cancer Care Market?
North America was the largest region in the clinical nutrition for cancer care market in 2025. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Clinical Nutrition For Cancer Care Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16017&type=smp
Browse Through More Reports Similar to the Global Clinical Nutrition For Cancer Care Market 2026, By The Business Research Company
Cancer Supportive Care Products Market Report 2026
Oncology Nutrition Market Report 2026
https://www.thebusinessresearchcompany.com/report/oncology-nutrition-global-market-report
Clinical Nutrition For Diabetes Care Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
